Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Liquidia assumed with an Underperform at Wedbush » 07:22
09/19/22
09/19
07:22
09/19/22
07:22
LQDA

Liquidia

$5.99 /

+0.04 (+0.67%)

, UTHR

United Therapeutics

$218.05 /

-2.665 (-1.21%)

Wedbush analyst Andreas…

Wedbush analyst Andreas Argyrides assumed coverage of Liquidia (LQDA) with an Underperform rating and $3 price target. The analyst notes that his firm recently downgraded shares to Underperform following the split decision in the Hatch-Waxman litigation with United Therapeutics (UTHR) that has at the moment blocked YUTREPIA from the market until mid-2024 at the earliest. Argyrides sees this delay as a meaningful setback allowing Tyvaso DPI a 2-year market advantage and the opportunity for other drugs in development to impact the PAH treatment landscape. It is possible YUTREPIA could be further barred from the market until 2027 if United is granted an injunction and/or wins on appeal of the '793 PTAB decision or the '066 District Court decision, he adds.

ShowHide Related Items >><<
UTHR United Therapeutics
$218.05 /

-2.665 (-1.21%)

LQDA Liquidia
$5.99 /

+0.04 (+0.67%)

LQDA Liquidia
$5.99 /

+0.04 (+0.67%)

09/01/22 Needham
Liquidia price target raised to $16 from $12 at Needham
09/01/22 H.C. Wainwright
Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright
09/01/22 Wedbush
Wedbush downgrades Liquidia to Underperform, lowers price target to $3
09/01/22 Wedbush
Liquidia downgraded to Underperform from Neutral at Wedbush
UTHR United Therapeutics
$218.05 /

-2.665 (-1.21%)

08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
05/26/22 BofA
BofA starts Liquidia Technologies at Buy, cites Yutrepia advantage over Tyvaso
UTHR United Therapeutics
$218.05 /

-2.665 (-1.21%)

LQDA Liquidia
$5.99 /

+0.04 (+0.67%)

  • 15
    Apr
UTHR United Therapeutics
$218.05 /

-2.665 (-1.21%)

LQDA Liquidia
$5.99 /

+0.04 (+0.67%)

LQDA Liquidia
$5.99 /

+0.04 (+0.67%)

Over a month ago
On The Fly
What You Missed On Wall Street On Thursday » 16:39
09/01/22
09/01
16:39
09/01/22
16:39
NVDA

Nvidia

$139.44 /

-11.51 (-7.63%)

, AMD

AMD

$82.35 /

-2.5 (-2.95%)

, CPB

Campbell Soup

$49.36 /

-1.025 (-2.03%)

, NVO

Novo Nordisk

$104.56 /

-1.51 (-1.42%)

, FMTX

Forma Therapeutics

$20.25 /

+6.86 (+51.23%)

, ILMN

Illumina

$200.63 /

-1.01 (-0.50%)

, BBBY

Bed Bath & Beyond

$8.71 /

-0.815 (-8.56%)

, WDC

Western Digital

$41.98 /

-0.285 (-0.67%)

, STX

Seagate

$65.92 /

-1.05 (-1.57%)

, VMC

Vulcan Materials

$166.23 /

-0.38 (-0.23%)

, HPQ

HP Inc.

$28.18 /

-0.515 (-1.80%)

, BIDU

Baidu

$144.50 /

+0.58 (+0.40%)

, POWW

AMMO

$3.72 /

-0.1 (-2.62%)

, MSFT

Microsoft

$260.66 /

-0.8 (-0.31%)

, ATVI

Activision Blizzard

$78.55 /

+0.05 (+0.06%)

, F

Ford

$15.19 /

-0.065 (-0.43%)

, CVX

Chevron

$155.54 /

-2.555 (-1.62%)

, TRQ

Turquoise Hill

$31.29 /

+3.75 (+13.62%)

, RIO

Rio Tinto

$54.34 /

-1.93 (-3.43%)

, NTNX

Nutanix

$22.32 /

+5.01 (+28.94%)

, SMTC

Semtech

$33.68 /

-12.49 (-27.05%)

, MDB

MongoDB

$241.10 /

-81.7 (-25.31%)

, LQDA

Liquidia

$4.88 /

-0.91 (-15.72%)

, ASAN

Asana

$17.82 /

-1.305 (-6.83%)

, UTHR

United Therapeutics

$226.15 /

-0.575 (-0.25%)

, OKTA

Okta

$60.58 /

-30.92 (-33.79%)

, PSTG

Pure Storage

$28.22 /

-0.775 (-2.67%)

, FIVE

Five Below

$135.97 /

+7.85 (+6.13%)

, SIG

Signet Jewelers

$57.51 /

-7.98 (-12.19%)

, HRL

Hormel Foods

$47.00 /

-3.26 (-6.49%)

Get caught up quickly on…

ShowHide Related Items >><<
WDC Western Digital
$41.98 /

-0.285 (-0.67%)

VMC Vulcan Materials
$166.23 /

-0.38 (-0.23%)

UTHR United Therapeutics
$226.15 /

-0.575 (-0.25%)

TRQ Turquoise Hill
$31.29 /

+3.75 (+13.62%)

STX Seagate
$65.92 /

-1.05 (-1.57%)

SMTC Semtech
$33.68 /

-12.49 (-27.05%)

SIG Signet Jewelers
$57.51 /

-7.98 (-12.19%)

RIO Rio Tinto
$54.34 /

-1.93 (-3.43%)

PSTG Pure Storage
$28.22 /

-0.775 (-2.67%)

POWW AMMO
$3.72 /

-0.1 (-2.62%)

OKTA Okta
$60.58 /

-30.92 (-33.79%)

NVO Novo Nordisk
$104.56 /

-1.51 (-1.42%)

NVDA Nvidia
$139.44 /

-11.51 (-7.63%)

NTNX Nutanix
$22.32 /

+5.01 (+28.94%)

MSFT Microsoft
$260.66 /

-0.8 (-0.31%)

MDB MongoDB
$241.10 /

-81.7 (-25.31%)

LQDA Liquidia
$4.88 /

-0.91 (-15.72%)

ILMN Illumina
$200.63 /

-1.01 (-0.50%)

HRL Hormel Foods
$47.00 /

-3.26 (-6.49%)

HPQ HP Inc.
$28.18 /

-0.515 (-1.80%)

FIVE Five Below
$135.97 /

+7.85 (+6.13%)

F Ford
$15.19 /

-0.065 (-0.43%)

CVX Chevron
$155.54 /

-2.555 (-1.62%)

CPB Campbell Soup
$49.36 /

-1.025 (-2.03%)

BIDU Baidu
$144.50 /

+0.58 (+0.40%)

BBBY Bed Bath & Beyond
$8.71 /

-0.815 (-8.56%)

ATVI Activision Blizzard
$78.55 /

+0.05 (+0.06%)

ASAN Asana
$17.82 /

-1.305 (-6.83%)

AMD AMD
$82.35 /

-2.5 (-2.95%)

NVDA Nvidia
$139.44 /

-11.51 (-7.63%)

09/02/22 Jefferies
Nvidia's 8% one-day selloff an 'overreaction,' says Jefferies
09/02/22 Daiwa
Nvidia downgraded to Neutral from Outperform at Daiwa
09/01/22 Piper Sandler
Nvidia price target lowered to $200 from $235 at Piper Sandler
09/01/22 JPMorgan
Nvidia working to limit downside risk of export ban, says JPMorgan
AMD AMD
$82.35 /

-2.5 (-2.95%)

08/30/22 Citi
Citi sees PHLX Semiconductor Sector Index to hit new lows, fall another 25%
08/03/22 Northland
AMD price target raised to $105 from $95 at Northland
08/03/22 KGI Securities
AMD upgraded to Outperform from Neutral at KGI Securities
08/03/22 JPMorgan
AMD price target lowered to $120 from $140 at JPMorgan
CPB Campbell Soup
$49.36 /

-1.025 (-2.03%)

09/02/22 Piper Sandler
Campbell Soup price target lowered to $46 from $47 at Piper Sandler
08/25/22 JPMorgan
Campbell Soup price target raised to $49 from $46 at JPMorgan
08/22/22 Deutsche Bank
Campbell Soup price target raised to $50 from $49 at Deutsche Bank
07/26/22 Morgan Stanley
Walmart warning reinforces cautious view of packaged food, says Morgan Stanley
NVO Novo Nordisk
$104.56 /

-1.51 (-1.42%)

09/02/22 H.C. Wainwright
Forma Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
09/01/22 Oppenheimer
Forma Therapeutics downgraded to Perform from Outperform at Oppenheimer
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Barclays
Novo Nordisk price target lowered to DKK 825 from DKK 875 at Barclays
FMTX Forma Therapeutics
$20.25 /

+6.86 (+51.23%)

09/02/22 Jefferies
Forma Therapeutics downgraded to Hold from Buy at Jefferies
09/02/22 Credit Suisse
Forma Therapeutics downgraded to Neutral from Outperform at Credit Suisse
ILMN Illumina
$200.63 /

-1.01 (-0.50%)

08/29/22 Piper Sandler
Illumina named new top pick at Piper Sandler
08/24/22 Credit Suisse
Illumina initiated with a Neutral at Credit Suisse
08/22/22 Citi
Citi adds 'positive Catalyst Watch' on Illumina into investor day
08/17/22 UBS
Illumina price target lowered to $245 from $350 at UBS
BBBY Bed Bath & Beyond
$8.71 /

-0.815 (-8.56%)

09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
09/01/22 Raymond James
Bed Bath & Beyond downgraded to Underperform from Market Perform at Raymond James
08/18/22 Wedbush
Wedbush downgrades Bed Bath & Beyond to sell on Cohen exit signal
WDC Western Digital
$41.98 /

-0.285 (-0.67%)

09/01/22 Benchmark
Western Digital downgraded to Sell at Benchmark following Seagate's forecast
09/01/22 Benchmark
Western Digital downgraded to Sell from Hold at Benchmark
08/16/22 Credit Suisse
Western Digital initiated with a Neutral at Credit Suisse
08/08/22 Craig-Hallum
Western Digital price target lowered to $85 from $90 at Craig-Hallum
STX Seagate
$65.92 /

-1.05 (-1.57%)

09/01/22 BofA
Seagate price target lowered to $93 from $110 at BofA
09/01/22 Craig-Hallum
Seagate price target lowered to $61 from $79 at Craig-Hallum
09/01/22 Northland
Seagate price target lowered to $88 from $105 at Northland
09/01/22 Stifel
Seagate price target lowered to $97 from $120 at Stifel
VMC Vulcan Materials
$166.23 /

-0.38 (-0.23%)

09/01/22 Vertical Research
Vulcan Materials upgraded to Buy from Hold at Vertical Research
08/18/22 Raymond James
Vulcan Materials assumed with Outperform from Market Perform at Raymond James
07/19/22 DA Davidson
Vulcan Materials price target lowered to $195 from $220 at DA Davidson
07/14/22 Wolfe Research
Vulcan Materials price target lowered to $194 from $211 at Wolfe Research
HPQ HP Inc.
$28.18 /

-0.515 (-1.80%)

09/01/22 Loop Capital
HP Inc. cut to Hold at Loop Capital on Poly integration, slowing demand
09/01/22 Mizuho
Seagate price target lowered to $75 from $83 at Mizuho
09/01/22 Loop Capital
HP Inc. downgraded to Hold from Buy at Loop Capital
08/31/22 Morgan Stanley
HP Inc. price target lowered to $28 from $30 at Morgan Stanley
BIDU Baidu
$144.50 /

+0.58 (+0.40%)

08/31/22 JPMorgan
Baidu upgraded to Overweight at JPMorgan on margin recovery
08/31/22 JPMorgan
Baidu upgraded to Overweight from Neutral at JPMorgan
08/31/22 Citi
Baidu price target lowered to $204 from $223 at Citi
08/23/22 Macquarie
Baidu initiated with an Outperform at Macquarie
POWW AMMO
$3.72 /

-0.1 (-2.62%)

08/16/22 Lake Street
AMMO price target lowered to $9 from $12 at Lake Street
06/30/22 EF Hutton
AMMO shares should be bought 'aggressively,' says EF Hutton
MSFT Microsoft
$260.66 /

-0.8 (-0.31%)

08/29/22 BMO Capital
Okta price target lowered to $110 from $125 at BMO Capital
08/29/22 Citi
Amazon deal for Electronic Arts would bring regulatory risks, says Citi
08/16/22 Citi
Zoom Video downgraded to Sell from Neutral at Citi
08/11/22 Guggenheim
Microsoft initiated with a Neutral at Guggenheim
ATVI Activision Blizzard
$78.55 /

+0.05 (+0.06%)

08/04/22 Deutsche Bank
Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank
07/25/22 MoffettNathanson
Activision Blizzard upgraded to Outperform at MoffettNathanson
05/31/22 Benchmark
Marcus, Imax, WWE added to entertainment top ideas list at Benchmark
05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
F Ford
$15.19 /

-0.065 (-0.43%)

08/24/22 Bernstein
Tesla, General Motors among big winners from IRA, says Bernstein
08/02/22 Citi
Citi ticks up Ford target, closes 'Upside Catalyst Watch'
08/01/22 Benchmark
Ford price target lowered to $23 from $25 at Benchmark
07/28/22 Deutsche Bank
Ford price target raised to $13 from $12 at Deutsche Bank
CVX Chevron
$155.54 /

-2.555 (-1.62%)

08/22/22 BMO Capital
Chevron execution to remain strong, says BMO Capital
08/15/22 Cowen
Chevron price target raised to $120 from $119 at Cowen
08/10/22 Credit Suisse
Chevron assumed with an Outperform at Credit Suisse
08/04/22 Societe Generale
Chevron upgraded at Societe Generale after 'impressive' results and return plans
TRQ Turquoise Hill
$31.29 /

+3.75 (+13.62%)

08/25/22 TD Securities
Turquoise Hill price target raised to C$40 from C$34 at TD Securities
08/16/22 TD Securities
Turquoise Hill price target lowered to C$34 from C$38 at TD Securities
08/08/22 Canaccord
Turquoise Hill price target lowered to C$42 from C$44 at Canaccord
08/08/22 TD Securities
Turquoise Hill price target lowered to C$38 from C$40 at TD Securities
RIO Rio Tinto
$54.34 /

-1.93 (-3.43%)

08/23/22 Macquarie
Rio Tinto downgraded to Neutral from Outperform at Macquarie
08/16/22 Morgan Stanley
Rio Tinto price target lowered to 5,900 GBp from 5,990 GBp at Morgan Stanley
07/29/22 Berenberg
Rio Tinto price target raised to 4,300 GBp from 4,100 GBp at Berenberg
07/28/22 JPMorgan
Rio Tinto price target raised to 5,350 GBp from 5,300 GBp at JPMorgan
NTNX Nutanix
$22.32 /

+5.01 (+28.94%)

09/01/22 Needham
Nutanix price target raised to $25 from $20 at Needham
09/01/22 RBC Capital
Nutanix price target raised to $24 from $21 at RBC Capital
09/01/22 Barclays
Nutanix price target raised to $25 from $22 at Barclays
09/01/22 Piper Sandler
Nutanix price target raised to $29 from $25 at Piper Sandler
SMTC Semtech
$33.68 /

-12.49 (-27.05%)

09/01/22 B. Riley
Semtech price target lowered to $53 from $63 at B. Riley
09/01/22 Benchmark
Semtech positions should be added to on weakness, says Benchmark
09/01/22 Oppenheimer
Semtech cut to Perform at Oppenheimer after in-line results, lower guidance
09/01/22 Oppenheimer
Semtech downgraded to Perform from Outperform at Oppenheimer
MDB MongoDB
$241.10 /

-81.7 (-25.31%)

09/01/22 Needham
MongoDB price target lowered to $330 from $350 at Needham
09/01/22 Stifel
Stifel trims MongoDB price target to $320, says commentary creates opportunity
09/01/22 Canaccord
MongoDB price target raised to $360 from $300 at Canaccord
09/01/22 Baird
MongoDB price target lowered to $330 from $360 at Baird
LQDA Liquidia
$4.88 /

-0.91 (-15.72%)

09/01/22 Needham
Liquidia price target raised to $16 from $12 at Needham
09/01/22 H.C. Wainwright
Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright
09/01/22 Wedbush
Wedbush downgrades Liquidia to Underperform, lowers price target to $3
09/01/22 Wedbush
Liquidia downgraded to Underperform from Neutral at Wedbush
ASAN Asana
$17.82 /

-1.305 (-6.83%)

09/01/22 Citi
Asana initiated with a Neutral at Citi
07/19/22 RBC Capital
Asana cut to Underperform at RBC Capital on amid unclear path to profitability
07/19/22 RBC Capital
Asana downgraded to Underperform from Sector Perform at RBC Capital
07/18/22 Piper Sandler
Asana price target lowered to $22 from $35 at Piper Sandler
UTHR United Therapeutics
$226.15 /

-0.575 (-0.25%)

08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
05/26/22 BofA
BofA starts Liquidia Technologies at Buy, cites Yutrepia advantage over Tyvaso
OKTA Okta
$60.58 /

-30.92 (-33.79%)

09/01/22 JMP Securities
Okta price target lowered to $145 from $165 at JMP Securities
09/01/22 BTIG
Okta price target lowered to $117 from $152 at BTIG
09/01/22 Truist
Okta price target lowered to $100 from $140 at Truist
PSTG Pure Storage
$28.22 /

-0.775 (-2.67%)

09/01/22 Northland
Pure Storage price target raised to $47 from $44 at Northland
09/01/22 Lake Street
Pure Storage price target raised to $38 from $36 at Lake Street
09/01/22 Morgan Stanley
Pure Storage price target raised to $35 from $33 at Morgan Stanley
09/01/22 Wedbush
Pure Storage price target raised to $35 from $30 at Wedbush
FIVE Five Below
$135.97 /

+7.85 (+6.13%)

09/01/22 Guggenheim
Five Below price target lowered to $190 from $200 at Guggenheim
09/01/22 Craig-Hallum
Five Below price target lowered to $178 from $185 at Craig-Hallum
09/01/22 Truist
Five Below price target raised to $156 from $154 at Truist
09/01/22 JPMorgan
Five Below price target lowered to $159 from $165 at JPMorgan
SIG Signet Jewelers
$57.51 /

-7.98 (-12.19%)

08/10/22 Citi
Signet Jewelers price target lowered to $65 from $76 at Citi
06/10/22 UBS
Signet Jewelers price target lowered to $120 from $138 at UBS
06/10/22 Citi
Signet Jewelers price target lowered to $76 from $94 at Citi
04/05/22 Wells Fargo
Signet Jewelers price target lowered to $105 from $140 at Wells Fargo
HRL Hormel Foods
$47.00 /

-3.26 (-6.49%)

09/02/22 Piper Sandler
Hormel Foods price target lowered to $47 from $48 at Piper Sandler
08/23/22 Stephens
Hormel Foods price target raised to $55 from $50 at Stephens
03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
03/10/22 Argus
Hormel Foods upgraded to Buy at Argus on pricing power
WDC Western Digital
$41.98 /

-0.285 (-0.67%)

VMC Vulcan Materials
$166.23 /

-0.38 (-0.23%)

UTHR United Therapeutics
$226.15 /

-0.575 (-0.25%)

TRQ Turquoise Hill
$31.29 /

+3.75 (+13.62%)

STX Seagate
$65.92 /

-1.05 (-1.57%)

SMTC Semtech
$33.68 /

-12.49 (-27.05%)

SIG Signet Jewelers
$57.51 /

-7.98 (-12.19%)

PSTG Pure Storage
$28.22 /

-0.775 (-2.67%)

POWW AMMO
$3.72 /

-0.1 (-2.62%)

OKTA Okta
$60.58 /

-30.92 (-33.79%)

NVO Novo Nordisk
$104.56 /

-1.51 (-1.42%)

NVDA Nvidia
$139.44 /

-11.51 (-7.63%)

NTNX Nutanix
$22.32 /

+5.01 (+28.94%)

MSFT Microsoft
$260.66 /

-0.8 (-0.31%)

MDB MongoDB
$241.10 /

-81.7 (-25.31%)

LQDA Liquidia
$4.88 /

-0.91 (-15.72%)

ILMN Illumina
$200.63 /

-1.01 (-0.50%)

HRL Hormel Foods
$47.00 /

-3.26 (-6.49%)

HPQ HP Inc.
$28.18 /

-0.515 (-1.80%)

FMTX Forma Therapeutics
$20.25 /

+6.86 (+51.23%)

FIVE Five Below
$135.97 /

+7.85 (+6.13%)

F Ford
$15.19 /

-0.065 (-0.43%)

CVX Chevron
$155.54 /

-2.555 (-1.62%)

CPB Campbell Soup
$49.36 /

-1.025 (-2.03%)

BIDU Baidu
$144.50 /

+0.58 (+0.40%)

BBBY Bed Bath & Beyond
$8.71 /

-0.815 (-8.56%)

ATVI Activision Blizzard
$78.55 /

+0.05 (+0.06%)

ASAN Asana
$17.82 /

-1.305 (-6.83%)

AMD AMD
$82.35 /

-2.5 (-2.95%)

  • 15
    Apr
WDC Western Digital
$41.98 /

-0.285 (-0.67%)

SMTC Semtech
$33.68 /

-12.49 (-27.05%)

RIO Rio Tinto
$54.34 /

-1.93 (-3.43%)

PSTG Pure Storage
$28.22 /

-0.775 (-2.67%)

POWW AMMO
$3.72 /

-0.1 (-2.62%)

OKTA Okta
$60.58 /

-30.92 (-33.79%)

NVO Novo Nordisk
$104.56 /

-1.51 (-1.42%)

NVDA Nvidia
$139.44 /

-11.51 (-7.63%)

NTNX Nutanix
$22.32 /

+5.01 (+28.94%)

MSFT Microsoft
$260.66 /

-0.8 (-0.31%)

ILMN Illumina
$200.63 /

-1.01 (-0.50%)

HPQ HP Inc.
$28.18 /

-0.515 (-1.80%)

F Ford
$15.19 /

-0.065 (-0.43%)

CVX Chevron
$155.54 /

-2.555 (-1.62%)

BIDU Baidu
$144.50 /

+0.58 (+0.40%)

BBBY Bed Bath & Beyond
$8.71 /

-0.815 (-8.56%)

ATVI Activision Blizzard
$78.55 /

+0.05 (+0.06%)

AMD AMD
$82.35 /

-2.5 (-2.95%)

WDC Western Digital
$41.98 /

-0.285 (-0.67%)

VMC Vulcan Materials
$166.23 /

-0.38 (-0.23%)

UTHR United Therapeutics
$226.15 /

-0.575 (-0.25%)

TRQ Turquoise Hill
$31.29 /

+3.75 (+13.62%)

STX Seagate
$65.92 /

-1.05 (-1.57%)

SIG Signet Jewelers
$57.51 /

-7.98 (-12.19%)

PSTG Pure Storage
$28.22 /

-0.775 (-2.67%)

POWW AMMO
$3.72 /

-0.1 (-2.62%)

NVO Novo Nordisk
$104.56 /

-1.51 (-1.42%)

NVDA Nvidia
$139.44 /

-11.51 (-7.63%)

NTNX Nutanix
$22.32 /

+5.01 (+28.94%)

MSFT Microsoft
$260.66 /

-0.8 (-0.31%)

ILMN Illumina
$200.63 /

-1.01 (-0.50%)

F Ford
$15.19 /

-0.065 (-0.43%)

CVX Chevron
$155.54 /

-2.555 (-1.62%)

CPB Campbell Soup
$49.36 /

-1.025 (-2.03%)

BIDU Baidu
$144.50 /

+0.58 (+0.40%)

BBBY Bed Bath & Beyond
$8.71 /

-0.815 (-8.56%)

ASAN Asana
$17.82 /

-1.305 (-6.83%)

AMD AMD
$82.35 /

-2.5 (-2.95%)

WDC Western Digital
$41.98 /

-0.285 (-0.67%)

STX Seagate
$65.92 /

-1.05 (-1.57%)

SIG Signet Jewelers
$57.51 /

-7.98 (-12.19%)

RIO Rio Tinto
$54.34 /

-1.93 (-3.43%)

PSTG Pure Storage
$28.22 /

-0.775 (-2.67%)

POWW AMMO
$3.72 /

-0.1 (-2.62%)

OKTA Okta
$60.58 /

-30.92 (-33.79%)

NVO Novo Nordisk
$104.56 /

-1.51 (-1.42%)

NVDA Nvidia
$139.44 /

-11.51 (-7.63%)

NTNX Nutanix
$22.32 /

+5.01 (+28.94%)

MSFT Microsoft
$260.66 /

-0.8 (-0.31%)

MDB MongoDB
$241.10 /

-81.7 (-25.31%)

LQDA Liquidia
$4.88 /

-0.91 (-15.72%)

ILMN Illumina
$200.63 /

-1.01 (-0.50%)

HPQ HP Inc.
$28.18 /

-0.515 (-1.80%)

FIVE Five Below
$135.97 /

+7.85 (+6.13%)

F Ford
$15.19 /

-0.065 (-0.43%)

CVX Chevron
$155.54 /

-2.555 (-1.62%)

CPB Campbell Soup
$49.36 /

-1.025 (-2.03%)

BIDU Baidu
$144.50 /

+0.58 (+0.40%)

BBBY Bed Bath & Beyond
$8.71 /

-0.815 (-8.56%)

ATVI Activision Blizzard
$78.55 /

+0.05 (+0.06%)

ASAN Asana
$17.82 /

-1.305 (-6.83%)

AMD AMD
$82.35 /

-2.5 (-2.95%)

Recommendations
Liquidia price target raised to $16 from $12 at Needham » 13:08
09/01/22
09/01
13:08
09/01/22
13:08
LQDA

Liquidia

$5.05 /

-0.74 (-12.78%)

Needham analyst Serge…

Needham analyst Serge Belanger raised the firm's price target on Liquidia to $16 from $12 and keeps a Buy rating on the shares, noting that "investors may be disappointed by the split decision court ruling," but contending that the decision "avoids the worst case scenario of an injunction until 2028" and establishes "a clear viable path" toward Yutepria approval by late-2023 or early-2024. The analyst, who also argues that recent developments should increase the appeal of Liquidia as an M&A target, said his increased target reflects both a lower risk profile and an updated model that now includes PHILD patients.

ShowHide Related Items >><<
LQDA Liquidia
$5.05 /

-0.74 (-12.78%)

LQDA Liquidia
$5.05 /

-0.74 (-12.78%)

09/01/22 H.C. Wainwright
Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright
09/01/22 Wedbush
Wedbush downgrades Liquidia to Underperform, lowers price target to $3
09/01/22 Wedbush
Liquidia downgraded to Underperform from Neutral at Wedbush
08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
LQDA Liquidia
$5.05 /

-0.74 (-12.78%)

  • 15
    Apr
LQDA Liquidia
$5.05 /

-0.74 (-12.78%)

LQDA Liquidia
$5.05 /

-0.74 (-12.78%)

On The Fly
What You Missed On Wall Street This Morning » 12:11
09/01/22
09/01
12:11
09/01/22
12:11
NVDA

Nvidia

$133.73 /

-17.22 (-11.41%)

, AMD

AMD

$78.96 /

-5.89 (-6.94%)

, HRL

Hormel Foods

$47.48 /

-2.78 (-5.53%)

, CPB

Campbell Soup

$48.81 /

-1.57 (-3.12%)

, NVO

Novo Nordisk

$104.02 /

-2.05 (-1.93%)

, FMTX

Forma Therapeutics

$19.93 /

+6.54 (+48.84%)

, BBBY

Bed Bath & Beyond

$8.87 /

-0.655 (-6.88%)

, WDC

Western Digital

$40.75 /

-1.515 (-3.58%)

, STX

Seagate

$64.02 /

-2.95 (-4.40%)

, VMC

Vulcan Materials

$164.60 /

-2.01 (-1.21%)

, HPQ

HP Inc.

$27.77 /

-0.92 (-3.21%)

, BIDU

Baidu

$142.42 /

-1.5 (-1.04%)

, IAC

IAC

$62.14 /

-2.2 (-3.42%)

, MTCH

Match Group

$53.59 /

-2.94 (-5.20%)

, POWW

AMMO

$3.64 /

-0.175 (-4.59%)

, MSFT

Microsoft

$255.58 /

-5.88 (-2.25%)

, ATVI

Activision Blizzard

$78.37 /

-0.13 (-0.17%)

, F

Ford

$14.89 /

-0.36 (-2.36%)

, TMUS

T-Mobile

$143.29 /

-0.62 (-0.43%)

, TRQ

Turquoise Hill

$31.20 /

+3.66 (+13.29%)

, RIO

Rio Tinto

$53.83 /

-2.445 (-4.35%)

, NTNX

Nutanix

$22.33 /

+5.02 (+29.00%)

, SMTC

Semtech

$31.95 /

-14.22 (-30.80%)

, MDB

MongoDB

$244.00 /

-78.8 (-24.41%)

, LQDA

Liquidia

$5.01 /

-0.78 (-13.47%)

, UTHR

United Therapeutics

$226.29 /

-0.43 (-0.19%)

, ASAN

Asana

$17.23 /

-1.89 (-9.88%)

, OKTA

Okta

$61.14 /

-30.36 (-33.18%)

, PSTG

Pure Storage

$27.79 /

-1.205 (-4.16%)

, FIVE

Five Below

$134.66 /

+6.54 (+5.10%)

, SIG

Signet Jewelers

$57.28 /

-8.21 (-12.54%)

, CIEN

Ciena

$45.56 /

-5.21 (-10.26%)

Get caught up quickly on…

ShowHide Related Items >><<
WDC Western Digital
$40.75 /

-1.515 (-3.58%)

VMC Vulcan Materials
$164.60 /

-2.01 (-1.21%)

UTHR United Therapeutics
$226.29 /

-0.43 (-0.19%)

TRQ Turquoise Hill
$31.20 /

+3.66 (+13.29%)

TMUS T-Mobile
$143.29 /

-0.62 (-0.43%)

STX Seagate
$64.02 /

-2.95 (-4.40%)

SMTC Semtech
$31.95 /

-14.22 (-30.80%)

SIG Signet Jewelers
$57.28 /

-8.21 (-12.54%)

RIO Rio Tinto
$53.83 /

-2.445 (-4.35%)

PSTG Pure Storage
$27.79 /

-1.205 (-4.16%)

POWW AMMO
$3.64 /

-0.175 (-4.59%)

OKTA Okta
$61.14 /

-30.36 (-33.18%)

NVO Novo Nordisk
$104.02 /

-2.05 (-1.93%)

NVDA Nvidia
$133.73 /

-17.22 (-11.41%)

NTNX Nutanix
$22.33 /

+5.02 (+29.00%)

MTCH Match Group
$53.59 /

-2.94 (-5.20%)

MSFT Microsoft
$255.58 /

-5.88 (-2.25%)

MDB MongoDB
$244.00 /

-78.8 (-24.41%)

LQDA Liquidia
$5.01 /

-0.78 (-13.47%)

IAC IAC
$62.14 /

-2.2 (-3.42%)

HRL Hormel Foods
$47.48 /

-2.78 (-5.53%)

HPQ HP Inc.
$27.77 /

-0.92 (-3.21%)

FIVE Five Below
$134.66 /

+6.54 (+5.10%)

F Ford
$14.89 /

-0.36 (-2.36%)

CPB Campbell Soup
$48.81 /

-1.57 (-3.12%)

CIEN Ciena
$45.56 /

-5.21 (-10.26%)

BIDU Baidu
$142.42 /

-1.5 (-1.04%)

BBBY Bed Bath & Beyond
$8.87 /

-0.655 (-6.88%)

ATVI Activision Blizzard
$78.37 /

-0.13 (-0.17%)

ASAN Asana
$17.23 /

-1.89 (-9.88%)

AMD AMD
$78.96 /

-5.89 (-6.94%)

NVDA Nvidia
$133.73 /

-17.22 (-11.41%)

09/01/22 Piper Sandler
Nvidia price target lowered to $200 from $235 at Piper Sandler
09/01/22 JPMorgan
Nvidia working to limit downside risk of export ban, says JPMorgan
09/01/22 Benchmark
Western Digital downgraded to Sell at Benchmark following Seagate's forecast
09/01/22 Bernstein
Nvidia price target lowered to $180 from $210 at Bernstein
AMD AMD
$78.96 /

-5.89 (-6.94%)

08/30/22 Citi
Citi sees PHLX Semiconductor Sector Index to hit new lows, fall another 25%
08/03/22 Northland
AMD price target raised to $105 from $95 at Northland
08/03/22 KGI Securities
AMD upgraded to Outperform from Neutral at KGI Securities
08/03/22 JPMorgan
AMD price target lowered to $120 from $140 at JPMorgan
HRL Hormel Foods
$47.48 /

-2.78 (-5.53%)

08/23/22 Stephens
Hormel Foods price target raised to $55 from $50 at Stephens
03/15/22 Goldman Sachs
Hormel Foods downgraded to Sell from Neutral at Goldman Sachs
03/10/22 Argus
Hormel Foods upgraded to Buy at Argus on pricing power
03/10/22 Argus
Hormel Foods upgraded to Buy from Hold at Argus
CPB Campbell Soup
$48.81 /

-1.57 (-3.12%)

08/25/22 JPMorgan
Campbell Soup price target raised to $49 from $46 at JPMorgan
08/22/22 Deutsche Bank
Campbell Soup price target raised to $50 from $49 at Deutsche Bank
07/26/22 Morgan Stanley
Walmart warning reinforces cautious view of packaged food, says Morgan Stanley
06/13/22 Piper Sandler
Campbell Soup price target raised to $47 from $45 at Piper Sandler
NVO Novo Nordisk
$104.02 /

-2.05 (-1.93%)

08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Barclays
Novo Nordisk price target lowered to DKK 825 from DKK 875 at Barclays
08/03/22 Piper Sandler
Piper says Altimmune selloff related to Novo continuing Phase 3 SELECT trial
07/15/22 Morgan Stanley
Novo Nordisk upgraded to Overweight from Equal Weight at Morgan Stanley
FMTX Forma Therapeutics
$19.93 /

+6.54 (+48.84%)

06/13/22 Cantor Fitzgerald
Forma Therapeutics assumed with an Overweight at Cantor Fitzgerald
06/13/22 Cantor Fitzgerald
Forma Therapeutics assumed with an Overweight at Cantor Fitzgerald
03/11/22 Cantor Fitzgerald
Forma Therapeutics price target lowered to $46 from $68 at Cantor Fitzgerald
03/02/22 Oppenheimer
Forma Therapeutics price target lowered to $49 from $60 at Oppenheimer
BBBY Bed Bath & Beyond
$8.87 /

-0.655 (-6.88%)

09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
09/01/22 Raymond James
Bed Bath & Beyond downgraded to Underperform from Market Perform at Raymond James
08/18/22 Wedbush
Wedbush downgrades Bed Bath & Beyond to sell on Cohen exit signal
WDC Western Digital
$40.75 /

-1.515 (-3.58%)

09/01/22 Benchmark
Western Digital downgraded to Sell from Hold at Benchmark
08/16/22 Credit Suisse
Western Digital initiated with a Neutral at Credit Suisse
08/08/22 Craig-Hallum
Western Digital price target lowered to $85 from $90 at Craig-Hallum
STX Seagate
$64.02 /

-2.95 (-4.40%)

09/01/22 BofA
Seagate price target lowered to $93 from $110 at BofA
09/01/22 Craig-Hallum
Seagate price target lowered to $61 from $79 at Craig-Hallum
09/01/22 Northland
Seagate price target lowered to $88 from $105 at Northland
09/01/22 Stifel
Seagate price target lowered to $97 from $120 at Stifel
VMC Vulcan Materials
$164.60 /

-2.01 (-1.21%)

09/01/22 Vertical Research
Vulcan Materials upgraded to Buy from Hold at Vertical Research
08/18/22 Raymond James
Vulcan Materials assumed with Outperform from Market Perform at Raymond James
07/19/22 DA Davidson
Vulcan Materials price target lowered to $195 from $220 at DA Davidson
07/14/22 Wolfe Research
Vulcan Materials price target lowered to $194 from $211 at Wolfe Research
HPQ HP Inc.
$27.77 /

-0.92 (-3.21%)

09/01/22 Loop Capital
HP Inc. cut to Hold at Loop Capital on Poly integration, slowing demand
09/01/22 Mizuho
Seagate price target lowered to $75 from $83 at Mizuho
09/01/22 Loop Capital
HP Inc. downgraded to Hold from Buy at Loop Capital
08/31/22 Morgan Stanley
HP Inc. price target lowered to $28 from $30 at Morgan Stanley
BIDU Baidu
$142.42 /

-1.5 (-1.04%)

08/31/22 JPMorgan
Baidu upgraded to Overweight at JPMorgan on margin recovery
08/31/22 JPMorgan
Baidu upgraded to Overweight from Neutral at JPMorgan
08/31/22 Citi
Baidu price target lowered to $204 from $223 at Citi
08/23/22 Macquarie
Baidu initiated with an Outperform at Macquarie
IAC IAC
$62.14 /

-2.2 (-3.42%)

08/11/22 Credit Suisse
IAC price target lowered to $121 from $127 at Credit Suisse
08/11/22 Cowen
IAC price target lowered to $124 from $130 at Cowen
08/11/22 Benchmark
IAC price target lowered to $150 from $175 at Benchmark
08/11/22 Piper Sandler
IAC price target lowered to $100 from $110 at Piper Sandler
MTCH Match Group
$53.59 /

-2.94 (-5.20%)

08/04/22 Cowen
Match Group price target lowered to $100 from $128 at Cowen
08/04/22 Deutsche Bank
Match Group price target lowered to $85 from $100 at Deutsche Bank
08/04/22 Susquehanna
Match Group price target lowered to $85 from $100 at Susquehanna
08/04/22 Oppenheimer
Match Group price target lowered to $78 from $100 at Oppenheimer
POWW AMMO
$3.64 /

-0.175 (-4.59%)

08/16/22 Lake Street
AMMO price target lowered to $9 from $12 at Lake Street
06/30/22 EF Hutton
AMMO shares should be bought 'aggressively,' says EF Hutton
MSFT Microsoft
$255.58 /

-5.88 (-2.25%)

08/29/22 BMO Capital
Okta price target lowered to $110 from $125 at BMO Capital
08/29/22 Citi
Amazon deal for Electronic Arts would bring regulatory risks, says Citi
08/16/22 Citi
Zoom Video downgraded to Sell from Neutral at Citi
08/11/22 Guggenheim
Microsoft initiated with a Neutral at Guggenheim
ATVI Activision Blizzard
$78.37 /

-0.13 (-0.17%)

08/04/22 Deutsche Bank
Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank
07/25/22 MoffettNathanson
Activision Blizzard upgraded to Outperform at MoffettNathanson
05/31/22 Benchmark
Marcus, Imax, WWE added to entertainment top ideas list at Benchmark
05/06/22 Benchmark
Playstudios could still be target as industry consolidates, says Benchmark
F Ford
$14.89 /

-0.36 (-2.36%)

08/24/22 Bernstein
Tesla, General Motors among big winners from IRA, says Bernstein
08/02/22 Citi
Citi ticks up Ford target, closes 'Upside Catalyst Watch'
08/01/22 Benchmark
Ford price target lowered to $23 from $25 at Benchmark
07/28/22 Deutsche Bank
Ford price target raised to $13 from $12 at Deutsche Bank
TMUS T-Mobile
$143.29 /

-0.62 (-0.43%)

08/30/22 Morgan Stanley
T-Mobile named a 'Catalyst Driven Idea' at Morgan Stanley
08/18/22 MoffettNathanson
T-Mobile price target raised to $174 from $165 at MoffettNathanson
07/28/22 Cowen
T-Mobile price target raised to $187 from $179 at Cowen
07/28/22 Barclays
T-Mobile price target raised to $160 from $150 at Barclays
TRQ Turquoise Hill
$31.20 /

+3.66 (+13.29%)

08/25/22 TD Securities
Turquoise Hill price target raised to C$40 from C$34 at TD Securities
08/16/22 TD Securities
Turquoise Hill price target lowered to C$34 from C$38 at TD Securities
08/08/22 Canaccord
Turquoise Hill price target lowered to C$42 from C$44 at Canaccord
08/08/22 TD Securities
Turquoise Hill price target lowered to C$38 from C$40 at TD Securities
RIO Rio Tinto
$53.83 /

-2.445 (-4.35%)

08/23/22 Macquarie
Rio Tinto downgraded to Neutral from Outperform at Macquarie
08/16/22 Morgan Stanley
Rio Tinto price target lowered to 5,900 GBp from 5,990 GBp at Morgan Stanley
07/29/22 Berenberg
Rio Tinto price target raised to 4,300 GBp from 4,100 GBp at Berenberg
07/28/22 JPMorgan
Rio Tinto price target raised to 5,350 GBp from 5,300 GBp at JPMorgan
NTNX Nutanix
$22.33 /

+5.02 (+29.00%)

09/01/22 Needham
Nutanix price target raised to $25 from $20 at Needham
09/01/22 RBC Capital
Nutanix price target raised to $24 from $21 at RBC Capital
09/01/22 Barclays
Nutanix price target raised to $25 from $22 at Barclays
09/01/22 Piper Sandler
Nutanix price target raised to $29 from $25 at Piper Sandler
SMTC Semtech
$31.95 /

-14.22 (-30.80%)

09/01/22 B. Riley
Semtech price target lowered to $53 from $63 at B. Riley
09/01/22 Benchmark
Semtech positions should be added to on weakness, says Benchmark
09/01/22 Oppenheimer
Semtech cut to Perform at Oppenheimer after in-line results, lower guidance
09/01/22 Oppenheimer
Semtech downgraded to Perform from Outperform at Oppenheimer
MDB MongoDB
$244.00 /

-78.8 (-24.41%)

09/01/22 Needham
MongoDB price target lowered to $330 from $350 at Needham
09/01/22 Stifel
Stifel trims MongoDB price target to $320, says commentary creates opportunity
09/01/22 Canaccord
MongoDB price target raised to $360 from $300 at Canaccord
09/01/22 Baird
MongoDB price target lowered to $330 from $360 at Baird
LQDA Liquidia
$5.01 /

-0.78 (-13.47%)

09/01/22 H.C. Wainwright
Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright
09/01/22 Wedbush
Wedbush downgrades Liquidia to Underperform, lowers price target to $3
09/01/22 Wedbush
Liquidia downgraded to Underperform from Neutral at Wedbush
08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
UTHR United Therapeutics
$226.29 /

-0.43 (-0.19%)

08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
05/26/22 BofA
BofA starts Liquidia Technologies at Buy, cites Yutrepia advantage over Tyvaso
ASAN Asana
$17.23 /

-1.89 (-9.88%)

09/01/22 Citi
Asana initiated with a Neutral at Citi
07/19/22 RBC Capital
Asana cut to Underperform at RBC Capital on amid unclear path to profitability
07/19/22 RBC Capital
Asana downgraded to Underperform from Sector Perform at RBC Capital
07/18/22 Piper Sandler
Asana price target lowered to $22 from $35 at Piper Sandler
OKTA Okta
$61.14 /

-30.36 (-33.18%)

09/01/22 JMP Securities
Okta price target lowered to $145 from $165 at JMP Securities
09/01/22 BTIG
Okta price target lowered to $117 from $152 at BTIG
09/01/22 Truist
Okta price target lowered to $100 from $140 at Truist
09/01/22 Stifel
Stifel says Okta 'squarely in penalty box,' lowers price target to $85
PSTG Pure Storage
$27.79 /

-1.205 (-4.16%)

09/01/22 Northland
Pure Storage price target raised to $47 from $44 at Northland
09/01/22 Lake Street
Pure Storage price target raised to $38 from $36 at Lake Street
09/01/22 Morgan Stanley
Pure Storage price target raised to $35 from $33 at Morgan Stanley
09/01/22 Wedbush
Pure Storage price target raised to $35 from $30 at Wedbush
FIVE Five Below
$134.66 /

+6.54 (+5.10%)

09/01/22 Guggenheim
Five Below price target lowered to $190 from $200 at Guggenheim
09/01/22 Craig-Hallum
Five Below price target lowered to $178 from $185 at Craig-Hallum
09/01/22 Truist
Five Below price target raised to $156 from $154 at Truist
09/01/22 JPMorgan
Five Below price target lowered to $159 from $165 at JPMorgan
SIG Signet Jewelers
$57.28 /

-8.21 (-12.54%)

08/10/22 Citi
Signet Jewelers price target lowered to $65 from $76 at Citi
06/10/22 UBS
Signet Jewelers price target lowered to $120 from $138 at UBS
06/10/22 Citi
Signet Jewelers price target lowered to $76 from $94 at Citi
04/05/22 Wells Fargo
Signet Jewelers price target lowered to $105 from $140 at Wells Fargo
CIEN Ciena
$45.56 /

-5.21 (-10.26%)

08/30/22 Loop Capital
Setup for Ciena Q3 looks 'extremely attractive', says Loop Capital
08/12/22 Morgan Stanley
Ciena upgraded to Overweight at Morgan Stanley as supply chain improves
08/12/22 Morgan Stanley
Ciena upgraded to Overweight from Equal Weight at Morgan Stanley
08/04/22 MKM Partners
Ciena assumed with a Buy at MKM Partners
WDC Western Digital
$40.75 /

-1.515 (-3.58%)

VMC Vulcan Materials
$164.60 /

-2.01 (-1.21%)

UTHR United Therapeutics
$226.29 /

-0.43 (-0.19%)

TRQ Turquoise Hill
$31.20 /

+3.66 (+13.29%)

TMUS T-Mobile
$143.29 /

-0.62 (-0.43%)

STX Seagate
$64.02 /

-2.95 (-4.40%)

SMTC Semtech
$31.95 /

-14.22 (-30.80%)

SIG Signet Jewelers
$57.28 /

-8.21 (-12.54%)

PSTG Pure Storage
$27.79 /

-1.205 (-4.16%)

POWW AMMO
$3.64 /

-0.175 (-4.59%)

OKTA Okta
$61.14 /

-30.36 (-33.18%)

NVO Novo Nordisk
$104.02 /

-2.05 (-1.93%)

NVDA Nvidia
$133.73 /

-17.22 (-11.41%)

NTNX Nutanix
$22.33 /

+5.02 (+29.00%)

MTCH Match Group
$53.59 /

-2.94 (-5.20%)

MSFT Microsoft
$255.58 /

-5.88 (-2.25%)

MDB MongoDB
$244.00 /

-78.8 (-24.41%)

LQDA Liquidia
$5.01 /

-0.78 (-13.47%)

IAC IAC
$62.14 /

-2.2 (-3.42%)

HRL Hormel Foods
$47.48 /

-2.78 (-5.53%)

HPQ HP Inc.
$27.77 /

-0.92 (-3.21%)

FMTX Forma Therapeutics
$19.93 /

+6.54 (+48.84%)

FIVE Five Below
$134.66 /

+6.54 (+5.10%)

F Ford
$14.89 /

-0.36 (-2.36%)

CPB Campbell Soup
$48.81 /

-1.57 (-3.12%)

CIEN Ciena
$45.56 /

-5.21 (-10.26%)

BIDU Baidu
$142.42 /

-1.5 (-1.04%)

BBBY Bed Bath & Beyond
$8.87 /

-0.655 (-6.88%)

ATVI Activision Blizzard
$78.37 /

-0.13 (-0.17%)

ASAN Asana
$17.23 /

-1.89 (-9.88%)

AMD AMD
$78.96 /

-5.89 (-6.94%)

  • 15
    Apr
  • 09
    Sep
WDC Western Digital
$40.75 /

-1.515 (-3.58%)

TMUS T-Mobile
$143.29 /

-0.62 (-0.43%)

SMTC Semtech
$31.95 /

-14.22 (-30.80%)

RIO Rio Tinto
$53.83 /

-2.445 (-4.35%)

PSTG Pure Storage
$27.79 /

-1.205 (-4.16%)

POWW AMMO
$3.64 /

-0.175 (-4.59%)

OKTA Okta
$61.14 /

-30.36 (-33.18%)

NVO Novo Nordisk
$104.02 /

-2.05 (-1.93%)

NVDA Nvidia
$133.73 /

-17.22 (-11.41%)

NTNX Nutanix
$22.33 /

+5.02 (+29.00%)

MTCH Match Group
$53.59 /

-2.94 (-5.20%)

MSFT Microsoft
$255.58 /

-5.88 (-2.25%)

IAC IAC
$62.14 /

-2.2 (-3.42%)

HPQ HP Inc.
$27.77 /

-0.92 (-3.21%)

F Ford
$14.89 /

-0.36 (-2.36%)

BIDU Baidu
$142.42 /

-1.5 (-1.04%)

BBBY Bed Bath & Beyond
$8.87 /

-0.655 (-6.88%)

ATVI Activision Blizzard
$78.37 /

-0.13 (-0.17%)

AMD AMD
$78.96 /

-5.89 (-6.94%)

WDC Western Digital
$40.75 /

-1.515 (-3.58%)

VMC Vulcan Materials
$164.60 /

-2.01 (-1.21%)

UTHR United Therapeutics
$226.29 /

-0.43 (-0.19%)

TRQ Turquoise Hill
$31.20 /

+3.66 (+13.29%)

TMUS T-Mobile
$143.29 /

-0.62 (-0.43%)

STX Seagate
$64.02 /

-2.95 (-4.40%)

SIG Signet Jewelers
$57.28 /

-8.21 (-12.54%)

PSTG Pure Storage
$27.79 /

-1.205 (-4.16%)

POWW AMMO
$3.64 /

-0.175 (-4.59%)

OKTA Okta
$61.14 /

-30.36 (-33.18%)

NVO Novo Nordisk
$104.02 /

-2.05 (-1.93%)

NVDA Nvidia
$133.73 /

-17.22 (-11.41%)

NTNX Nutanix
$22.33 /

+5.02 (+29.00%)

MTCH Match Group
$53.59 /

-2.94 (-5.20%)

MSFT Microsoft
$255.58 /

-5.88 (-2.25%)

LQDA Liquidia
$5.01 /

-0.78 (-13.47%)

IAC IAC
$62.14 /

-2.2 (-3.42%)

HRL Hormel Foods
$47.48 /

-2.78 (-5.53%)

HPQ HP Inc.
$27.77 /

-0.92 (-3.21%)

FIVE Five Below
$134.66 /

+6.54 (+5.10%)

F Ford
$14.89 /

-0.36 (-2.36%)

CPB Campbell Soup
$48.81 /

-1.57 (-3.12%)

CIEN Ciena
$45.56 /

-5.21 (-10.26%)

BIDU Baidu
$142.42 /

-1.5 (-1.04%)

BBBY Bed Bath & Beyond
$8.87 /

-0.655 (-6.88%)

ASAN Asana
$17.23 /

-1.89 (-9.88%)

AMD AMD
$78.96 /

-5.89 (-6.94%)

WDC Western Digital
$40.75 /

-1.515 (-3.58%)

TMUS T-Mobile
$143.29 /

-0.62 (-0.43%)

STX Seagate
$64.02 /

-2.95 (-4.40%)

SIG Signet Jewelers
$57.28 /

-8.21 (-12.54%)

RIO Rio Tinto
$53.83 /

-2.445 (-4.35%)

PSTG Pure Storage
$27.79 /

-1.205 (-4.16%)

POWW AMMO
$3.64 /

-0.175 (-4.59%)

OKTA Okta
$61.14 /

-30.36 (-33.18%)

NVO Novo Nordisk
$104.02 /

-2.05 (-1.93%)

NVDA Nvidia
$133.73 /

-17.22 (-11.41%)

NTNX Nutanix
$22.33 /

+5.02 (+29.00%)

MTCH Match Group
$53.59 /

-2.94 (-5.20%)

MSFT Microsoft
$255.58 /

-5.88 (-2.25%)

MDB MongoDB
$244.00 /

-78.8 (-24.41%)

LQDA Liquidia
$5.01 /

-0.78 (-13.47%)

HPQ HP Inc.
$27.77 /

-0.92 (-3.21%)

FIVE Five Below
$134.66 /

+6.54 (+5.10%)

F Ford
$14.89 /

-0.36 (-2.36%)

CPB Campbell Soup
$48.81 /

-1.57 (-3.12%)

BIDU Baidu
$142.42 /

-1.5 (-1.04%)

BBBY Bed Bath & Beyond
$8.87 /

-0.655 (-6.88%)

ATVI Activision Blizzard
$78.37 /

-0.13 (-0.17%)

ASAN Asana
$17.23 /

-1.89 (-9.88%)

AMD AMD
$78.96 /

-5.89 (-6.94%)

Recommendations
Liquidia IPR win on '793 patent offers path for appeals, says H.C. Wainwright » 11:54
09/01/22
09/01
11:54
09/01/22
11:54
LQDA

Liquidia

$4.67 /

-1.12 (-19.34%)

, UTHR

United Therapeutics

$226.68 /

-0.04 (-0.02%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Andrew Fein presented his thoughts on the implications and expectations for both Liquidia (LQDA) and United Therapeutics (UTHR) following the Hatch-Waxman district court decision, stating that the district court ruling on the '793 patent "was a setback," but adding that Liquidia already won on the '793 patent in the IPR decision, which he sees "offering a clear path forward for appeals." In his view, the main conclusions from the announced Hatch-Waxman decision specifically determined that the asserted claims of the '066 patent were either invalid or not infringed, favoring Liquidia, and the asserted claims of the '793 patent were valid and infringed, favoring United "at this stage." The appeal process could be expected to take upwards of 14-18 months, said Fein, who acknowledges that in the scenario where the '793 patent is ultimately determined to remain intact despite appeals, final Yutrepia approval could be pushed to expiration of the '793 patent in May 2027. He maintains a Buy rating and $16 price target on Liquidia shares.

ShowHide Related Items >><<
UTHR United Therapeutics
$226.68 /

-0.04 (-0.02%)

LQDA Liquidia
$4.67 /

-1.12 (-19.34%)

LQDA Liquidia
$4.67 /

-1.12 (-19.34%)

09/01/22 Wedbush
Wedbush downgrades Liquidia to Underperform, lowers price target to $3
09/01/22 Wedbush
Liquidia downgraded to Underperform from Neutral at Wedbush
08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
UTHR United Therapeutics
$226.68 /

-0.04 (-0.02%)

07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
05/26/22 BofA
BofA starts Liquidia Technologies at Buy, cites Yutrepia advantage over Tyvaso
05/24/22 Jefferies
United Therapeutics price target raised to $245 from $223 at Jefferies
UTHR United Therapeutics
$226.68 /

-0.04 (-0.02%)

LQDA Liquidia
$4.67 /

-1.12 (-19.34%)

  • 15
    Apr
UTHR United Therapeutics
$226.68 /

-0.04 (-0.02%)

LQDA Liquidia
$4.67 /

-1.12 (-19.34%)

LQDA Liquidia
$4.67 /

-1.12 (-19.34%)

Downgrade
Wedbush downgrades Liquidia to Underperform, lowers price target to $3 » 07:44
09/01/22
09/01
07:44
09/01/22
07:44
LQDA

Liquidia

$5.79 /

+0.395 (+7.32%)

As previously reported,…

As previously reported, Wedbush analyst Liana Moussatos downgraded Liquidia to Underperform from Neutral with a price target of $3, down from $4, as pushing the full approval and potential U.S. launch of YUTREPIA to mid-2024 from November 2022 allows United to gain an even greater advantage growing the number of patients on Tyvaso DPI as well as gives potentially disease-modifying candidates like sotatercept the opportunity to disrupt the PAH market. The analyst also sees TKI DPIs AV-101 and seralutinib entering the market as early as 2026 with high likelihood of rapid adoption in the PAH market if they can show reversal and remodeling of the pulmonary vasculature. In the near-term, Moussatos notes Liquidia has no other product than YUTREPIA in its pipeline with no upcoming catalysts leaving limited opportunity for near-term value creation.

ShowHide Related Items >><<
LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

09/01/22 Wedbush
Liquidia downgraded to Underperform from Neutral at Wedbush
08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

  • 15
    Apr
LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

Downgrade
Liquidia downgraded to Underperform from Neutral at Wedbush » 07:16
09/01/22
09/01
07:16
09/01/22
07:16
LQDA

Liquidia

$5.79 /

+0.395 (+7.32%)

Wedbush analyst Liana…

Wedbush analyst Liana Moussatos downgraded Liquidia to Underperform from Neutral with a $3 price target.

ShowHide Related Items >><<
LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
07/22/22 Ladenburg
Liquidia Technologies initiated with a Buy at Ladenburg
LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

  • 15
    Apr
LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

Hot Stocks
United Therapeutics 'pleased' with court decision in patent litigation » 18:46
08/31/22
08/31
18:46
08/31/22
18:46
UTHR

United Therapeutics

$226.66 /

+7.35 (+3.35%)

, LQDA

Liquidia

$5.79 /

+0.395 (+7.32%)

United Therapeutics…

United Therapeutics Corporation (UTHR) announced that the United States District Court for the District of Delaware issued an opinion in the pending litigation concerning United Therapeutics' U.S. patents 9,593,066 and 10,716,793. This litigation concerns whether Liquidia Technologies, Inc.'s (LQDA) proposed treprostinil inhalation powder, Yutrepia, would infringe the '066 and '793 patents. The Court determined that Liquidia would induce infringement of various claims of the '793 patent by marketing Yutrepia. The '793 patent relates to a method of administering treprostinil via inhalation. The Court also concluded that Liquidia failed to prove that any claim of the '793 patent at issue is invalid. As a result of the Court's decision, United Therapeutics expects the Court to enter an injunction barring the U.S. Food and Drug Administration from granting final approval for Yutrepia until expiration of the '793 patent, May 14, 2027, as required by 35 U.S.C. Section 271(e)(4)(A). The Court also determined that Yutrepia would infringe several claims of the '066 patent, but found those claims to be invalid. The '066 patent relates to a method of making treprostinil, the active pharmaceutical ingredient in both Tyvaso Inhalation Solution and Tyvaso DPI Inhalation Powder. Both parties have the right to appeal. United Therapeutics is evaluating the Court's opinion and next steps, including the potential for appealing the Court's decisions on the '066 patent. "We're pleased with the Court's decision on the '793 patent, and our legal team is evaluating options for the '066 patent," said Shaun Snader, Vice President and Associate General Counsel - IP and Litigation at United Therapeutics. "Today's decision vindicates our claims that Yutrepia is an infringing product, and we will continue to vigorously defend our intellectual property."

ShowHide Related Items >><<
UTHR United Therapeutics
$226.66 /

+7.35 (+3.35%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

UTHR United Therapeutics
$226.66 /

+7.35 (+3.35%)

08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
05/26/22 BofA
BofA starts Liquidia Technologies at Buy, cites Yutrepia advantage over Tyvaso
05/24/22 Jefferies
United Therapeutics price target raised to $245 from $223 at Jefferies
LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
07/22/22 Ladenburg
Liquidia Technologies initiated with a Buy at Ladenburg
UTHR United Therapeutics
$226.66 /

+7.35 (+3.35%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

  • 15
    Apr
UTHR United Therapeutics
$226.66 /

+7.35 (+3.35%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

LQDA Liquidia
$5.79 /

+0.395 (+7.32%)

Hot Stocks
Judge issues opinion in Liquidia, United Therapeutics patent fight » 15:05
08/31/22
08/31
15:05
08/31/22
15:05
LQDA

Liquidia

$6.21 /

+0.815 (+15.11%)

, UTHR

United Therapeutics

$224.19 /

+4.88 (+2.23%)

A trial opinion in the…

A trial opinion in the U.S. District Court for the District of Delaware suit between Liquidia (LQDA) and United Therapeutics (UTHR) posted to the site of the court states: "UTC failed to prove by a preponderance of the evidence that Liquidia will infringe claim 8 of the ' 066 patent. Liquidia proved by clear and convincing evidence that claims 1, 2, 3, 6, and 9 of the '066 patent are invalid. UTC proved by a preponderance of the evidence that Liquidia will induce infringement of claims 1, 4, 6, 7, and 8 of the '793 patent." Liquidia shares, which have been volatile in afternoon trading, are up 43c, or 8%, to $5.81 near 3 pm ET.

ShowHide Related Items >><<
UTHR United Therapeutics
$224.19 /

+4.88 (+2.23%)

LQDA Liquidia
$6.21 /

+0.815 (+15.11%)

LQDA Liquidia
$6.21 /

+0.815 (+15.11%)

08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
07/22/22 Ladenburg
Liquidia Technologies initiated with a Buy at Ladenburg
UTHR United Therapeutics
$224.19 /

+4.88 (+2.23%)

05/26/22 BofA
BofA starts Liquidia Technologies at Buy, cites Yutrepia advantage over Tyvaso
05/24/22 Jefferies
United Therapeutics price target raised to $245 from $223 at Jefferies
UTHR United Therapeutics
$224.19 /

+4.88 (+2.23%)

LQDA Liquidia
$6.21 /

+0.815 (+15.11%)

  • 15
    Apr
UTHR United Therapeutics
$224.19 /

+4.88 (+2.23%)

LQDA Liquidia
$6.21 /

+0.815 (+15.11%)

LQDA Liquidia
$6.21 /

+0.815 (+15.11%)

Hot Stocks
Liquidia Technologies trading resumes  14:37
08/31/22
08/31
14:37
08/31/22
14:37
LQDA

Liquidia

$5.52 /

+0.125 (+2.32%)

 
ShowHide Related Items >><<
LQDA Liquidia
$5.52 /

+0.125 (+2.32%)

LQDA Liquidia
$5.52 /

+0.125 (+2.32%)

08/31/22 Ladenburg
Ladenburg keeps Buy on Liquidia, says patent stay denial doesn't alter thesis
08/30/22 BofA
Liquidia stay denial not 'a material setback,' says BofA
07/22/22 Ladenburg
Ladenburg starts Liquidia Technologies at Buy with $15 price target
07/22/22 Ladenburg
Liquidia Technologies initiated with a Buy at Ladenburg
LQDA Liquidia
$5.52 /

+0.125 (+2.32%)

  • 15
    Apr
LQDA Liquidia
$5.52 /

+0.125 (+2.32%)

LQDA Liquidia
$5.52 /

+0.125 (+2.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.